PeraMobile and PeraWatch vs ContaCT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by PeraHealth (acquired by Spacelabs Healthcare)
VS
by Viz.AI

AI Verdict

Tool A focuses on general patient deterioration and acuity scoring across the hospital using predictive analytics to identify at-risk patients. In contrast, Tool B specializes in AI-powered detection of specific acute diseases, such as stroke, and streamlines care coordination for those time-sensitive conditions, often involving medical imaging. Therefore, they are adjacent tools, each addressing different critical aspects of clinical decision support.

Choose PeraMobile and PeraWatch if…

Choose PeraMobile and PeraWatch if your primary goal is system-wide patient surveillance and early detection of general patient deterioration across various conditions. This tool excels at providing real-time patient acuity scoring (Rothman Index) to proactively identify at-risk patients for earlier intervention, aiming to improve overall quality and reduce costs.

View PeraMobile and PeraWatch →

Choose ContaCT if…

Choose ContaCT by Viz.ai if your focus is on accelerating the detection and streamlining care coordination for specific acute conditions like stroke, pulmonary embolism, or cardiac issues. This AI-powered platform is designed to provide real-time alerts and facilitate rapid communication among specialists, ensuring timely treatment for time-sensitive diagnoses.

View ContaCT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature PeraMobile and PeraWatch ContaCT
Pricing Contact for pricing Subscription-based
Deployment Software-only, integrated with EHRs, web-based access, mobile application, on user-provided hardware. Cloud-based, integrates with existing hospital IT infrastructure (PACS, EHR).
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ContaCT

Tool B (ContaCT) emphasizes a 'High-fidelity 3D web and mobile image viewer' and 'Secure, HIPAA-compliant group communication messaging,' suggesting a more comprehensive and interactive user experience tailored for specialists needing to collaborate on imaging. While Tool A (PeraMobile/PeraWatch) offers mobile access and dashboards, Tool B's features point to a more specialized and potentially richer interactive experience for its target users in critical care scenarios.

Clinical Value

ContaCT

While both tools offer significant clinical value and are FDA-cleared, Tool B's (ContaCT) focus on accelerating detection and streamlining workflows for time-sensitive, critical conditions like stroke, PE, and aneurysms directly impacts patient morbidity and mortality in a highly measurable way. Its widespread adoption across over 1,700 hospitals globally for these specific use cases demonstrates a strong, proven clinical impact.

Pricing & Value

Tie

Both tools are enterprise-level solutions with non-publicly disclosed pricing, requiring direct contact for quotes. While Tool B mentions a 'subscription-based' and 'tiered' model, which could imply flexibility, neither provides enough detail to definitively assess their pricing transparency or value proposition against the other.

Enterprise Readiness

ContaCT

Viz.ai's ContaCT explicitly states HIPAA compliance and having a Business Associate Agreement (BAA), and its deployment in over 1,700 hospitals globally demonstrates a proven track record of successful enterprise-level integration with PACS and EHR systems. While PeraHealth's solutions are likely compliant and integrate with EHRs, the explicit statements and extensive global adoption of Tool B provide stronger evidence of its enterprise readiness.

Innovation

ContaCT

Viz.ai's ContaCT is described as a 'pioneering AI-powered care coordination platform' with 'multiple FDA clearances' for AI-driven detection across a range of critical conditions like stroke, PE, and aneurysms. Features like automated chart summarization and guideline-based recommendations further highlight its advanced application of AI for broader clinical workflow optimization, indicating a higher degree of innovation.

Support & Docs

Tie

Both PeraHealth (now part of Spacelabs Healthcare) and Viz.ai operate in the enterprise healthcare software space, implying the necessity of robust customer support and documentation. While Spacelabs Healthcare, as a larger entity, likely has extensive support infrastructure, Viz.ai also emphasizes a strong 'customer success' approach with dedicated implementation and ongoing support. Without specific comparative details on their support offerings or documentation quality, it is difficult to definitively choose a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature PeraMobile and PeraWatch ContaCT
Product Name PeraMobile and PeraWatch ContaCT
Company PeraHealth (acquired by Spacelabs Healthcare) Viz.AI
Primary Use Case / Focus Identify at-risk patients sooner for earlier intervention, improve quality, and reduce costs (predictive analytics for patient deterioration). Accelerates disease detection and streamlines clinical workflows (AI-powered care coordination for stroke, LVO, ICH, HCM, PE, Aneurysm).
Key Technology / Algorithm Rothman Index AI-powered disease detection
Mobile Access Mobile access for on-the-go clinicians (PeraMobile) Mobile application for specialists to view images and communicate
EHR Integration Integration with major EHR vendors Integration with PACS and EHR systems

Videos

Demos, reviews, and walkthroughs featuring PeraMobile and PeraWatch and ContaCT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

PeraMobile and PeraWatch, powered by the Rothman Index, focus on predictive analytics to identify at-risk patients sooner for earlier intervention, aiming to improve quality and reduce costs by monitoring patient deterioration across various conditions. In contrast, ContaCT by Viz.ai is an AI-powered care coordination platform that accelerates the detection of specific diseases like large vessel occlusion (LVO) stroke, intracerebral hemorrhage (ICH), hypertrophic cardiomyopathy (HCM), pulmonary embolism (PE), and aneurysms, streamlining workflows for timely treatment.
PeraMobile and PeraWatch utilize the FDA-cleared Rothman Index, which is a comprehensive measure of patient condition based on physiological measures including labs, vital signs, and nursing assessments to provide a continuous acuity score and trend. ContaCT by Viz.ai employs AI-powered algorithms for disease detection and real-time alerts, analyzing medical imaging data such as CT scans to identify specific conditions and facilitate care coordination.
PeraMobile and PeraWatch are designed for system-wide virtual surveillance and real-time patient acuity scoring to identify general patient deterioration across various diseases and conditions. ContaCT by Viz.ai is specifically tailored for the detection and coordination of care for conditions such as large vessel occlusion (LVO) stroke, intracerebral hemorrhage (ICH), hypertrophic cardiomyopathy (HCM), pulmonary embolism (PE), and aneurysms.
PeraMobile and PeraWatch are software-only solutions that integrate with major EHR vendors and can be deployed on user-provided hardware, offering web-based access and a mobile application. ContaCT by Viz.ai is a cloud-based platform that integrates with existing hospital IT infrastructure, specifically PACS and EHR systems.
PeraMobile provides mobile access for on-the-go clinicians to track patients' changing conditions, view Rothman Index scores and trends, and receive configurable warning states and push notifications. ContaCT by Viz.ai offers a mobile application that allows specialists to view images, receive real-time AI-powered alerts and notifications for specific disease detections, and engage in secure, HIPAA-compliant group communication.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.